BNP PARIBAS ARBITRAGE/CALL/PFIZER INC/34/0.1/21.06.24 Stock

Warrant

GC3MB

NLBNPFR1W747

Real-time Euronext Paris 12:30:01 2024-05-21 EDT
0.015 EUR 0.00% Intraday chart for BNP PARIBAS ARBITRAGE/CALL/PFIZER INC/34/0.1/21.06.24
3 months-40.00%
Current year-76.92%
Date Price Change
24-05-21 0.015 0.00%
24-05-20 0.015 0.00%
24-05-17 0.015 0.00%
24-05-16 0.015 +200.00%
24-05-15 0.005 -50.00%

Real-time Euronext Paris

Last update May 21, 2024 at 12:30 pm

More quotes

Static data

Product typeWarrants
Buy / SellCALL
Underlying PFIZER, INC.
IssuerLogo Issuer BNP Paribas BNP Paribas
GC3MB
ISINNLBNPFR1W747
Date issued 2023-11-22
Strike 34 $
Maturity 2024-06-21 (30 Days)
Parity 10 : 1
Emission price 0.09
Emission volume N/A
Settlement règlement en espèces
Currency EUR

Technical Indicators

Highest since issue 0.145
Lowest since issue 0.001
Delta0.1x
Omega 17.36
Premium19.64x
Gearing169.66x
Moneyness 0.8400
Difference Strike 5.44 $
Difference Strike %+16.00%
Spread 0.029
Spread %96.67%
Theoretical value 0.0155
Implied Volatility 44.51 %
Total Loss Probability 91.87 %
Intrinsic value 0.000000
Present value 0.0155
Break even 34.17 €
Theta-0.01x
Vega0x
Rho0x

Company Profile

Pfizer, Inc. is the world's leading pharmaceutical group. Net sales break down by family of products as follows: - primary care products (72.8%): medicines used in internal medicine, vaccines, medicines for the prevention and treatment of Covid-19, antivirals, mRNA-based products, etc.; - specialty care products (13.8%): medicines used in immunology, in hospitals and for the treatment of rare diseases, anti-inflammatory medicines, etc.; - oncology products (12.1%); - other (1.3%). At the end of 2022, the group had more than 35 manufacturing sites worldwide. Net sales are distributed geographically as follows: the United States (42.3%), Europe (21.9%) and other (35.8%).
Sector
-
More about the company

Ratings for Pfizer, Inc.

Trading Rating
Investor Rating
ESG Refinitiv
C+
More Ratings

Consensus: Pfizer, Inc.

Sell
Consensus
Buy
Mean consensus
OUTPERFORM
Number of Analysts
25
Last Close Price
28.56 USD
Average target price
31.94 USD
Spread / Average Target
+11.83%
Consensus
  1. Stock Market
  2. Warrants
  3. GC3MB Warrant
-40% Exceptional extension: Our subscriptions help you unlock the best investment opportunities.
BENEFIT NOW